105
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like State

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Direct reprogramming of adult somatic cells into alternative cell types has been shown for several lineages. We previously showed that GATA4, MEF2C, and TBX5 (GMT) directly reprogrammed nonmyocyte mouse heart cells into induced cardiomyocyte-like cells (iCMs) in vitro and in vivo. However, GMT alone appears insufficient in human fibroblasts, at least in vitro. Here, we show that GMT plus ESRRG and MESP1 induced global cardiac gene-expression and phenotypic shifts in human fibroblasts derived from embryonic stem cells, fetal heart, and neonatal skin. Adding Myocardin and ZFPM2 enhanced reprogramming, including sarcomere formation, calcium transients, and action potentials, although the efficiency remained low. Human iCM reprogramming was epigenetically stable. Furthermore, we found that transforming growth factor β signaling was important for, and improved the efficiency of, human iCM reprogramming. These findings demonstrate that human fibroblasts can be directly reprogrammed toward the cardiac lineage, and lay the foundation for future refinements in vitro and in vivo.

          Highlights

          • Human fibroblasts can be directly induced toward a CM-like state by defined factors

          • Reprogramming of fibroblasts toward a CM state is epigenetically stable

          • Human and mouse in vitro iCMs display a comparable gene-expression shift

          • TGF-β signaling is important for human iCM reprogramming

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Direct conversion of fibroblasts to functional neurons by defined factors

          Cellular differentiation and lineage commitment are considered robust and irreversible processes during development. Recent work has shown that mouse and human fibroblasts can be reprogrammed to a pluripotent state with a combination of four transcription factors. This raised the question of whether transcription factors could directly induce other defined somatic cell fates, and not only an undifferentiated state. We hypothesized that combinatorial expression of neural lineage-specific transcription factors could directly convert fibroblasts into neurons. Starting from a pool of nineteen candidate genes, we identified a combination of only three factors, Ascl1, Brn2, and Myt1l, that suffice to rapidly and efficiently convert mouse embryonic and postnatal fibroblasts into functional neurons in vitro. These induced neuronal (iN) cells express multiple neuron-specific proteins, generate action potentials, and form functional synapses. Generation of iN cells from non-neural lineages could have important implications for studies of neural development, neurological disease modeling, and regenerative medicine.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

            Reprogramming of mouse and human somatic cells can be achieved by ectopic expression of transcription factors, but with low efficiencies. We report that DNA methyltransferase and histone deacetylase (HDAC) inhibitors improve reprogramming efficiency. In particular, valproic acid (VPA), an HDAC inhibitor, improves reprogramming efficiency by more than 100-fold, using Oct4-GFP as a reporter. VPA also enables efficient induction of pluripotent stem cells without introduction of the oncogene c-Myc.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

              SUMMARY The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported that cardiac fibroblasts, which represent 50% of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here, we use genetic lineage-tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became bi-nucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast activating peptide, Thymosin β4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Stem Cell Reports
                Stem Cell Reports
                Stem Cell Reports
                Elsevier
                2213-6711
                22 August 2013
                22 August 2013
                10 September 2013
                : 1
                : 3
                : 235-247
                Affiliations
                [1 ]Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA
                [2 ]Roddenberry Center for Stem Cell Biology and Medicine at Gladstone, San Francisco, CA 94158, USA
                [3 ]Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94158, USA
                [4 ]Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA 94158, USA
                [5 ]Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94158, USA
                [6 ]Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA
                Author notes
                []Corresponding author dsrivastava@ 123456gladstone.ucsf.edu
                [7]

                Present address: McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599-7126

                [8]

                Present address: Program in Physiology and Experimental Medicine, The Hospital for Sick Children, Toronto, ON, Canada M5G 1X8

                Article
                S2213-6711(13)00054-4
                10.1016/j.stemcr.2013.07.005
                3849259
                24319660
                6b7b7e65-ad86-4917-b1b2-c459f7ad9df9
                © 2013 The Authors

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 8 July 2013
                : 18 July 2013
                : 19 July 2013
                Categories
                Article

                Comments

                Comment on this article